Author Archives: Vicente Zaragozá

COMPAMED 2026: Manufacturing Will Shape the Next Generation of Medical Devices

Fluidnatek_team_COMPAMED

COMPAMED 2026 brought together companies and professionals from across the medical technology supply chain in Düsseldorf, Germany. For Fluidnatek, the event provided an opportunity to discuss the challenges shaping the industry, explore evolving manufacturing requirements and present our latest developments in electrospinning technology.

One message stood out across these discussions: advancing medical devices requires more than innovative materials and designs. It also demands controlled, reproducible manufacturing processes capable of translating material performance into reliable, consistent products.

Turning Material Innovation into Manufacturable Solutions

Advances in materials and device architectures are creating new opportunities in areas such as implantable technologies, tissue regeneration, advanced coatings and drug delivery. Translating these opportunities into viable medical solutions, however, depends on more than material performance alone.

As applications progress from research and development towards manufacturing, process reproducibility, scalability, quality and validation become increasingly important. Achieving batch-to-batch consistency requires control at multiple levels, including system-to-system matching, data-driven process control and robust environmental control.

These elements help ensure that process conditions can be understood, monitored and reproduced, providing a stronger foundation for consistent manufacturing outcomes.

Collaboration across the medical technology ecosystem is equally important. Material innovators, device developers, engineering teams and manufacturing technology providers all have a role to play in bridging the gap between promising concepts and reliable medical products.

Electrospinning’s Role in Medical Technology

Electrospinning enables the development of micro- and nanofibrous structures with properties that can be tailored to specific applications. These materials offer significant opportunities in areas including tissue-engineering scaffolds, implant coatings, membranes and drug-delivery systems.

Realizing this potential requires more than achieving the desired fiber morphology or material properties. A thorough understanding of process parameters, together with reliable control of operating and environmental conditions, is essential to obtaining consistent results.

Data-driven process control and robust environmental management are particularly important in this context. By monitoring and controlling critical process conditions, manufacturers can improve reproducibility, support consistent production and facilitate the transition from laboratory-scale development towards more controlled manufacturing workflows.

Introducing Fluidnatek MED: Supporting Medical Device Development and Manufacturing

At COMPAMED 2026, Fluidnatek introduced Fluidnatek MED, our new platform dedicated to electrospinning and electrospraying for medical device development and manufacturing.

Designed around different application requirements, Fluidnatek MED brings together specialized configurations for tubular structures and flat medical sheets, alongside a configurable research setup. 

The introduction of Fluidnatek MED reflects our commitment to addressing the specific requirements of medical technology, where material innovation must go hand in hand with process understanding, control and reproducibility.

Our approach places particular emphasis on system-to-system matching, data-driven process control and robust environmental control. Together, these principles support greater process consistency and reproducibility, helping researchers and manufacturers work towards reliable batch-to-batch results.

With Fluidnatek MED, we are taking another step towards supporting the development of advanced electrospun medical technologies and the manufacturing processes needed to bring them closer to application.

Looking Ahead

COMPAMED 2026 provided an opportunity to connect with professionals across the medical technology ecosystem, exchange technical insights and gain a clearer understanding of the challenges shaping the industry’s future.

The discussions in Düsseldorf reinforced an important principle: progress in medical technology depends not only on developing new materials and device concepts, but also on establishing the process control and manufacturing capabilities needed to translate them into reliable solutions.

We would like to thank everyone who met with the Fluidnatek team during COMPAMED 2026. We look forward to continuing these conversations and contributing to the development of the next generation of medical technologies.

Medical Technology Ireland 2026: What We Learned About Developing More Reliable Medical Devices

Medical Technology Ireland 2026

Medical Technology Ireland 2026 has come to a close, bringing together medical-device manufacturers, R&D teams, engineers, quality specialists and technology suppliers at Galway Racecourse.

For Fluidnatek, the event provided an opportunity not only to present our electrospinning technology, but also to exchange ideas with professionals involved in different stages of medical-device development. These conversations highlighted an important point: the successful development of a medical device increasingly depends on connecting material development with process understanding, manufacturing and quality requirements from the early stages.

Reproducibility Starts During Development

For electrospun materials, achieving the desired fiber morphology or structure is an important milestone, but it is not the end of the development process.

The properties of an electrospun material depend on multiple process variables, including solution characteristics, flow rate, applied voltage, collector configuration and environmental conditions. Understanding how these parameters influence the process is therefore essential when moving beyond an initial proof of concept.

This is particularly relevant for medical applications, where development teams need to establish processes that can be consistently understood, documented and reproduced.

Connecting R&D with Manufacturing

Another recurring theme from our conversations at Medical Technology Ireland was the importance of considering the next stage of development before it is reached.

A process that works at laboratory scale may require further optimization before it can be transferred to a larger system or manufacturing environment. Establishing appropriate process parameters, collecting development data and documenting operating conditions can provide a stronger basis for technology transfer and scale-up.

For electrospinning, this means that process development and material development should evolve together.

Environmental control can also become important as projects progress. Temperature and relative humidity can influence solvent evaporation, jet stability and fiber morphology, making controlled conditions valuable when reproducibility is a key requirement.

A More Integrated Approach to Medical-Device Development

The discussions at Medical Technology Ireland reinforced the importance of bringing different perspectives together throughout the development process.

Material scientists may focus on fiber structure and material performance. Engineers may be concerned with process control and equipment configuration. Quality teams need consistent and traceable processes, while manufacturing teams need solutions that can ultimately be transferred and scaled.

For electrospun medical materials, these requirements are closely connected.

Fluidnatek develops electrospinning and electrospraying platforms designed to support this progression, from early R&D and proof-of-concept work through process development and scale-up. The Fluidnatek LE-50 G2, for example, combines configurable electrospinning and electrospraying technologies with options for environmental control, process monitoring, data collection and programmable recipes.

Looking Ahead

Medical Technology Ireland reinforced a principle that is increasingly relevant to advanced medical-device development: a successful material is only part of the solution. The process used to produce it must also be understood, controlled and developed with future manufacturing requirements in mind.

We would like to thank the Medical Technology Ireland organizers and everyone who visited the Fluidnatek team at Booth L126 for the valuable conversations and technical discussions.

As medical-device developers continue to explore electrospun scaffolds, coatings, membranes, wound-care materials and drug-delivery systems, the challenge is not simply to achieve the desired material properties, but to develop processes that can support reliable and reproducible outcomes as projects move forward.

Electrospin 2026: Reproducibility Takes Center Stage in Nanofiber Development

2026 electrospin

Electrospin 2026, the 9th International Conference on Electrospinning, brought researchers, engineers, and industry teams together in Padova, Italy, from September 1–4 to explore the latest developments in electrospinning and nanofiber technology. The program covered a broad range of topics, including new polymers and composites, biomedical applications, filtration, energy, smart textiles, process fundamentals, and industrial implementation.

Fluidnatek participated alongside our Italian distributor Nanofaber, showcasing the Fluidnatek LE-50 Gen2 and exchanging perspectives with researchers and companies working across the electrospinning field.

Reproducibility is becoming a key development challenge

Producing nanofibers is no longer the only challenge. As electrospinning moves toward more demanding applications, researchers increasingly need to understand why a process works, how consistently it can be reproduced, and what is required to scale it.

Fiber diameter, morphology and material properties can be influenced by solution characteristics, flow rate, applied voltage, collector configuration, temperature and relative humidity. Controlling and monitoring these variables can therefore be critical when moving from an initial proof of concept toward a robust process.

This is particularly relevant in fields such as biomedicine, filtration, energy and technical textiles, where material performance needs to be combined with repeatable manufacturing.

Building better processes starts during R&D

One of the key takeaways from Electrospin 2026 was the importance of connecting materials development with process development.

Decisions made during early research — including equipment configuration, environmental control, solution delivery, process monitoring and data collection — can influence how easily a process can later be optimized and transferred to larger-scale production.

At Fluidnatek, this is why our approach to electrospinning and electrospraying combines process control, reproducibility and scalability across a portfolio covering laboratory R&D, process development, pilot production and industrial manufacturing.

The discussions at Electrospin 2026 reinforced a simple principle: successful nanofiber development is not only about achieving the right material structure once, but about understanding how to produce it consistently and reliably.

We thank the Electrospin community and our partner Nanofaber for the opportunity to share ideas and continue advancing the conversation around scalable electrospinning technologies.

From Materials Research to Medical Manufacturing

congress_Visitors

Innovation in electrospinning does not happen within a single discipline. It emerges through collaboration between materials scientists, biomedical researchers, medical device developers, and industrial manufacturers. Reflecting this multidisciplinary landscape, Fluidnatek will participate in five major European conferences throughout September, contributing to discussions that span the entire innovation journey—from materials research and process development to biomaterials, medical technologies, and industrial manufacturing

Dates and conferences:

  • Sept 1–4, 2026 — ELECTROSPIN (Padova, Italy)
    A specialist conference focused on electrospinning techniques, materials and applications. Ideal for researchers optimizing processes and for companies needing reproducible scaling and turnkey systems.
  • Sept 7–11, 2026 — 34th Annual Conference of the European Society for Biomaterials (Antwerp, Belgium)

A multidisciplinary biomaterials meeting covering preclinical testing to regulation and commercialization. A platform to engage with clinical groups and industry partners interested in implants and controlled drug delivery.

  • Sept 14–17, 2026 — XVIII Spanish Conference of Specialized Group on Polymers (GEP) (Valencia, Spain)

 Technical forum on polymers and applications, emphasizing innovation and tech transfer in Spain. An opportunity to showcase polymer formulations processable by electrospinning and discuss scaling with local R&D teams.

  • Sept 23–24, 2026 — MEDICAL TECHNOLOGY IRELAND (Galway, Ireland) Medical-technology event focused on industry–clinic collaboration and device supply chains. Perfect to present functional prototypes and manufacturing routes under regulatory constraints.
  • Sept 24–26, 2026 — GERMAN SOCIETY OF BIOMATERIALS (Aachen, Germany)

A rigorous biomaterials meeting with a strong orientation to clinical application and European standards. A key venue to validate electrospinning solutions with preclinical evaluators and manufacturing partners.

What we’ll showcase

  • Scalable, reproducible electrospinning equipment and processes, with performance data and traceability for regulated environments.
  • Live demonstrations of the Fluidnatek LE-50 Gen2 in operation, plus real collaboration case studies: from scaffolds for regeneration to drug-delivery patches and rapid prototyping tailored for industry needs.

We look forward to meeting researchers, manufacturers, and healthcare innovators throughout September to discuss their next electrospinning challenge. Whether the goal is process development, technology transfer, or industrial scale-up, our team will be available to explore practical solutions that help transform promising concepts into robust, reproducible manufacturing processes.

From Biomaterials to Medical Devices: Key Takeaways from Medical Technology Germany 2026

MedTechGermany_Fluidnatek

As medical technologies become increasingly sophisticated, manufacturing processes are evolving just as rapidly. Medical Technology Germany 2026 reflected this transformation, bringing together engineers, manufacturers, researchers, and regulatory specialists to discuss the technologies shaping the next generation of healthcare products.

As part of this year’s exhibition, Fluidnatek participated in these discussions by showcasing the Fluidnatek LE-50 Gen2 electrospinning platform and engaging with professionals developing advanced medical devices, biomaterials, tissue engineering solutions, wound care products, drug delivery systems, and other healthcare technologies.

Electrospinning Continues to Gain Momentum

Many of the conversations held during the event reflected the growing interest in electrospinning as an enabling manufacturing technology for medical innovation.

By allowing precise control over nanofiber architecture, electrospinning enables the development of materials with highly tailored structural and functional properties. This level of control is becoming increasingly important for applications where porosity, surface area, mechanical performance, or controlled therapeutic release directly influence clinical outcomes.

As more medical products move from laboratory research toward commercialization, manufacturers are also placing greater emphasis on process reproducibility, scalability, and manufacturing robustness. These requirements extend beyond material design and increasingly influence technology selection from the earliest stages of product development.

From Research to Industrial Manufacturing

One of the recurring themes throughout Medical Technology Germany was the importance of establishing manufacturing strategies that can successfully transition from proof-of-concept studies to industrial production.

This transition was a recurring topic in many technical discussions throughout the event. While every project presents unique challenges, successful technology transfer often depends on combining robust process development with scalable manufacturing strategies.

These principles are reflected in many of the collaborative projects developed by Fluidnatek together with medical technology companies, research organisations, and industrial manufacturers, several of which are featured in our Customer Success Stories.

During the exhibition, the Fluidnatek team discussed how electrospinning projects can be developed with scale-up in mind from the outset. Rather than treating research and manufacturing as separate stages, an integrated development approach helps reduce technical risk, improve process understanding, and facilitate future technology transfer.

Visitors also had the opportunity to see the Fluidnatek LE-50 Gen2 operating live, demonstrating the level of process control, environmental stability, and automation required to achieve reproducible electrospinning results.

Supporting the Future of Medical Innovation

Medical technology continues to evolve rapidly, driven by increasingly sophisticated biomaterials, regenerative medicine, personalized therapies, and advanced drug delivery platforms. As these technologies mature, manufacturing processes must evolve alongside them to deliver the consistency, traceability, and quality required for successful commercialization.

At Fluidnatek, we remain committed to supporting researchers and manufacturers throughout this journey—from early feasibility studies and process development to scale-up and industrial manufacturing.

We would like to thank everyone who visited our booth during Medical Technology Germany 2026. We appreciate the opportunity to exchange ideas, discuss technical challenges, and explore how electrospinning can contribute to the next generation of medical technologies.

Fluidnatek at RegMed XB 2026: Driving the Transition from Lab to Clinical Reality

fluidnatek regmed

The RegMed XB Annual Conference 2026 in Utrecht has come to a close, and for Fluidnatek, it was much more than just a date on the calendar. Represented by our colleague Pilar Salinas, we spent several intensive days fully immersed in the heart of the regenerative medicine ecosystem, engaging with the pioneers who are redefining the future of healthcare.

Our presence at RegMed XB was driven by a clear purpose: to support the transition from groundbreaking research to real-world patient impact. 

The Translation Challenge

At Fluidnatek, we believe that the next generation of cell and gene therapies, tissue engineering, and advanced biomaterials depends entirely on the enabling technologies behind them. A brilliant scientific concept remains a concept until it can be manufactured under rigorous standards and moved into clinical applications.

During her interactions with researchers, clinicians, and ATMP developers, Pilar noted a common priority: bridging between proof-of-concept and clinical reality. Whether it’s developing complex scaffolds for tissue engineering or precision drug delivery systems, the consensus was clear—process control and scalability are the new frontiers.

Scaling Innovation with Precision

Our participation reinforced the vital role that electrospinning and electrospraying play in this ecosystem. These aren’t just laboratory techniques; they are scalable manufacturing platforms that offer:

  • Unmatched Precision: Creating nanofibrous structures that mimic the natural extracellular matrix.
  • Reproducibility: Essential for meeting the stringent requirements of regulatory bodies and clinical trials.
  • Scalability: Moving from benchtop research to pilot manufacturing without losing the properties that make the material effective.

Looking Ahead

Regenerative medicine is a collaborative journey. Seeing the entire value chain—from investors to policymakers and scientists—gathered in one place reminds us why we do what we do. At Fluidnatek, we are committed to providing the advanced processing technology that turns visionary research into tangible medical solutions.

The conference may be over, but the work of scaling the future of medicine continues. We are ready to help you navigate the manufacturing challenges of your next breakthrough.

Exhibitors regmed

Electrospun Membranes for Distillation

Electrospun nanofiber membrane structure used in membrane distillation

Introduction: The Challenge of Thermal Separation Processes

Water desalination, wastewater treatment, and resource recovery all depend on efficient separation technologies capable of producing high-purity water while minimizing energy consumption. Among the emerging approaches being investigated, membrane distillation has attracted significant interest because it combines high salt rejection with relatively low operating temperatures. This makes it a promising technology for advanced water treatment applications.

The efficiency of membrane distillation depends strongly on membrane structure and surface chemistry. Parameters such as porosity, pore size distribution, pore tortuosity, thickness, and hydrophobicity directly influence vapor transport and heat transfer resistance.

In recent years, electrospun membranes for membrane distillation have been extensively investigated because electrospinning enables the fabrication of highly porous nanofiber structures with interconnected pore networks. These architectures can facilitate vapor diffusion while maintaining separation between the feed and permeate streams.

As a result, electrospun nanofiber membrane distillation systems are becoming an increasingly important research area in advanced water treatment and separation science.

What Is Membrane Distillation?

Membrane distillation is a thermally driven membrane separation process in which a hydrophobic semipermeable membrane separates a heated feed solution from a colder permeate side.

The process operates through a vapor pressure gradient generated by a temperature difference across the membrane. Water evaporates at the interface between the warm feed and the membrane, and the vapors diffuse through the membrane pores and condense at the colder permeate side.

Because the membrane is hydrophobic, liquid water is prevented from penetrating the pores, resulting in selective vapor transport.

The performance of membrane distillation membranes depends on several key parameters:

  • Membrane porosity
  • Pore size distribution
  • Membrane thickness
  • Thermal conductivity
  • Hydrophobicity
  • Pore tortuosity

These factors influence vapor flux, conductive heat loss, liquid entry pressure (LEP; the maximum working pressure for the membrane distillation process, above which liquid water would penetrate the membrane), and long-term operational stability.

Traditionally, membrane distillation membranes are designed with relatively high thicknesses to reduce conductive heat transfer between the feed and permeate streams. However, thicker membranes may also increase the resistance to vapor transport, thus reducing the vapor flux.

Consequently, membrane engineering for distillation requires balancing thermal insulation with efficient vapor transport.

Electrospun Membranes for Membrane Distillation

Electrospinning is a versatile fabrication technology capable of producing continuous nanofibers from polymer solutions using a strong electric field.

Electrospun nanofiber membranes typically exhibit:

  • High surface-area-to-volume ratio
  • High porosity
  • Interconnected pore structures
  • Tunable fiber diameters

These structural characteristics are advantageous for membrane distillation because they can facilitate vapor diffusion.

At the same time, electrospun membranes must maintain sufficient hydrophobicity to prevent membrane wetting during operation.

Research has demonstrated that fiber morphology significantly influences membrane wetting behavior and vapor transport performance.

However, smoother fibers may sometimes provide higher vapor flux because of differences in pore interconnectivity and membrane packing density.

These observations highlight the importance of carefully balancing:

  • Fiber morphology
  • Hydrophobicity
  • Porosity
  • Mechanical stability
  • Liquid entry pressure

when designing electrospun membranes for distillation applications.

Hydrophobic Nanofibers for Efficient Vapor Transport

Hydrophobicity is one of the most critical parameters in membrane distillation systems. If pore wetting occurs (i.e., if liquid water penetrates the membrane pores), the feed and permeate solutions come in direct contact with each-other, resulting in contamination of the permeate stream. This scenario is considered a critical failure of the membrane.

Electrospun poly (vinylidene fluoride) (PVDF) membranes have been widely investigated in the context of membrane distillation due to their intrinsic hydrophobicity, chemical resistance, and thermal stability.

Experimental studies have shown that electrospun PVDF membranes can achieve relatively high vapor permeation fluxes. However, electrospun structures often exhibit lower liquid entry pressure than commercial PTFE membranes, meaning the risk of pore wetting is higher.

For example, reported studies observed that electrospun PVDF membranes exhibited liquid entry pressure (LEP) values below 0.64 bar, whereas commercial PTFE membranes demonstrated substantially higher LEP values of approximately 9 bar. The relatively low LEP of the electrospun PVDF membranes indicated a greater susceptibility to pore wetting under pressure-driven conditions, although these membranes often exhibited higher vapor flux due to their highly porous nanofibrous structure.

Despite this limitation, electrospun PVDF membranes have demonstrated higher vapor flux in certain membrane distillation configurations due to their highly porous nanofibrous architecture.

These findings indicate that electrospun nanofiber membranes may offer important mass transport advantages, although long-term wetting resistance remains an active area of research.

Materials and Design Strategies for High-Performance Membranes

Polymer Selection for Membrane Distillation

The polymer used during electrospinning strongly influences membrane performance in membrane distillation applications.

Materials commonly investigated include:

  • Polyvinylidene fluoride (PVDF)
  • Polyurethane (PU)
  • Polystyrene (PS)
  • Polysulfone (PSU)
  • PVDF-HFP copolymers

These polymers differ in:

  • Hydrophobicity
  • Thermal stability
  • Mechanical resistance
  • Solvent compatibility
  • Processability

Experimental studies with electrospun polyurethane (PU) membranes demonstrated that membrane thickness and feed salinity significantly influence permeation flux. In the work reported by Feng, Khayet, and Matsuura in their study on electrospun nanofibrous membranes for membrane distillation, thin electrospun membranes (approximately 6–10 g m⁻²) achieved fluxes above 10 kg m⁻² h⁻¹ under the experimental conditions reported by the authors and at feed salinities below 20 wt. % NaCl.

As feed salinity increased, flux progressively decreased to approximately 8 kg m⁻² h⁻¹, highlighting the impact of concentration polarization and membrane wetting phenomena on membrane distillation performance. In contrast, thicker electrospun membranes exhibited lower but more stable flux values, typically between 6 and 8 kg m⁻² h⁻¹ across the tested salinity range.

The lower stability of thinner membranes was associated with larger pore sizes and lower bubble-point pressures, increasing susceptibility to membrane wetting.

Surface Engineering and Hydrophobic Modification

Several surface engineering strategies have been investigated to improve hydrophobicity and wetting resistance in electrospun membranes.

One reported approach involved electroless silver plating followed by 1-dodecanethiol surface modification of electrospun PVDF nanofibers. The resulting membrane achieved:

  • Water contact angle ≈153°
  • Sliding angle <10°

Under the reported experimental conditions, the modified membrane maintained a relatively stable vapor flux during eight hours of membrane distillation testing.

Other studies (Zhou et al. (2014) have reported PTFE nanofibrous membranes fabricated by electrospinning PTFE/PVA precursor suspensions followed by high-temperature sintering. In this approach, PVA acts as a carrier polymer during electrospinning, while the PTFE particles are subsequently fused during thermal treatment to generate a nanofibrous PTFE structure.

These membranes demonstrated:

  • Water contact angle ≈156.7°
  • Salt rejection >98 %

during vacuum membrane distillation experiments.

Such approaches illustrate how membrane surface engineering can improve wetting resistance and operational stability in membrane distillation systems.

 

Desalination plant in Germany.

Desalination plant in Germany.

Performance and Efficiency Advantages

Nanofiber Membranes for Desalination and Water Treatment

Several experimental studies have evaluated electrospun membranes in desalination and water purification applications.

One investigation involving electrospun polysulfone nanofibers modified with beeswax reported:

  • Water contact angle ≈162°
  • Salt rejection >99.8 %
  • Permeate flux ≈6.4 L m⁻² h⁻¹

during direct contact membrane distillation testing with sodium chloride feed solution.

The membrane exhibited relatively stable operation over extended testing periods, with only moderate flux decline reported after prolonged operation.

These results demonstrate the potential of electrospun membranes for advanced water treatment applications where high salt rejection and controlled vapor transport are required.

Multi-Layer Membrane Architectures

To improve wetting resistance and liquid entry pressure, researchers have explored multilayer membrane designs.

One reported configuration included:

  • Hydrophilic nanofiber support layer
  • Cast membrane intermediate layer
  • Superhydrophobic electrospun PVDF top layer

In this structure:

  • The superhydrophobic layer reduces pore wetting
  • The intermediate layer increases liquid entry pressure
  • The hydrophilic support assists vapor transport

Under reported experimental conditions, the membrane maintained stable permeation performance over extended operating periods while preserving high salt rejection.

Influence of Fiber Architecture

Recent studies have also investigated electrospun membranes containing bimodal fiber diameter distributions.

These structures combine fibers of different diameters within the same membrane, modifying pore architecture and vapor transport pathways.

Research involving PS, PVDF-HFP, and blended systems reported permeation fluxes up to approximately 43.41 L m⁻² h⁻¹ while maintaining salt rejection near 99.74%.

These findings suggest that fiber diameter distribution and structural organization may significantly influence membrane distillation performance.

Fluidnatek’s Role in Electrospun Membrane Development and Scale-Up

Advanced electrospinning equipment plays an important role in the development of nanofiber membranes for membrane distillation and thermal separation technologies.

Fluidnatek electrospinning platforms support controlled fabrication of nanofiber membranes by enabling adjustment of:

  • Fiber diameter
  • Membrane thickness
  • Porosity
  • Polymer solution formulation
  • Multi-layer architecture

Such process control capabilities are relevant for researchers investigating membrane distillation, desalination membranes, hydrophobic nanofiber systems, and advanced filtration materials.

Fluidnatek platforms also support process scalability from laboratory development toward pilot-scale and even full-scale manufacturing configurations, which is an important consideration for membrane technology translation.

Conclusion

Membrane distillation is an important emerging technology for desalination and water treatment.

Electrospun membranes for membrane distillation offer several potential advantages, including:

  • High porosity
  • Tunable nanofiber structures
  • Enhanced vapor transport
  • Flexible membrane architecture design

At the same time, challenges related to pore wetting and long-term hydrophobic stability remain active areas of scientific research.

Ongoing developments in polymer engineering, multilayer membrane architecture, and surface modifications continue to improve the performance of electrospun nanofiber membranes for distillation applications.

Although many of these technologies are still at the research and pilot scale, electrospinning is expected to play an increasingly important role in next-generation membrane distillation systems.

Accelerate Membrane Distillation Research with Fluidnatek

Looking to develop high-performance membranes for distillation and advanced separation technologies?

Fluidnatek’s electrospinning platforms support the development of customizable nanofiber membranes for membrane distillation, desalination research, filtration, and other water treatment applications.

Contact Fluidnatek’s technical team to explore scalable electrospinning solutions for membrane engineering and thermal separation research.

 

References

ElectrospinTech. Electrospun membrane for distillation.
http://electrospintech.com/memdistillation.html

Essalhi, M., & Khayet, M. (2014). Surface modification of electrospun PVDF membranes for membrane distillation. Desalination.

Liao, Y., et al. (2013). Superhydrophobic modification of electrospun PVDF nanofibers for membrane distillation.

Zhou, X., et al. (2014). Electrospun PTFE nanofiber membranes for vacuum membrane distillation.

Prince, J. A., et al. (2014). Triple-layer membranes for improved membrane distillation performance.

Zhao, S., et al. (2023). Bimodal fiber diameter electrospun membranes for membrane distillation.

Khayet, M., & Matsuura, T. (2011). Membrane Distillation: Principles and Applications. Elsevier.

Feng, C., Khayet, M., & Matsuura, T. Preparation and Characterization of Electrospun Nanofibrous Membranes for Membrane Distillation. In: Membrane Distillation: Principles and Applications. Elsevier.

 

 

Electrospinning Environmental Control: How Temperature and Humidity Shape Fiber Morphology — and Why the ECU Makes the Difference

Fluidnatek ECU is critical for biomedical and GMP applications.

Environmental conditions strongly affect electrospinning outcomes, especially fiber diameter, morphology, and batch-to-batch reproducibility. Relative humidity and temperature influence solvent evaporation, jet stability, and fiber solidification, making environmental control a critical part of process development. Fluidnatek’s Environmental Control Unit (ECU) provides control of temperature and humidity to support more consistent electrospinning results across biomedical and research applications.

Introduction: Why Environmental Control Matters in Electrospinning

Electrospinning is highly sensitive to ambient conditions. Even when voltage, flow rate, and tip-to-collector distance are well optimized, changes in temperature and humidity can alter the way a jet forms and dries, which in turn affects final fiber morphology.

This sensitivity becomes especially important in applications where fiber uniformity matters, such as biomedical scaffolds, drug delivery systems, and protein-based biomaterials. In these cases, small changes in environmental conditions can lead to differences in fiber diameter, surface texture, and defect formation.

For this reason, environmental control is not simply a convenience. It is a practical tool for improving reproducibility, reducing process variability, and supporting more reliable electrospinning development. The Fluidnatek ECU is designed specifically for this purpose, giving users a controlled chamber environment that helps them work within a stable and adaptable climate window.

Mechanisms: How Humidity and Temperature Affect Fiber Morphology

Relative Humidity and Solvent Evaporation

Relative humidity plays an important role in electrospinning because it affects how quickly solvent evaporates from the jet and how the fiber surface solidifies. When humidity is too high, evaporation may slow down, which can increase the risk of surface pores, ribbon-like fibers, or other morphology changes. When humidity is too low, the jet may dry too quickly, which can also contribute to instability or defects in some systems.

The effect is not identical for every polymer or solvent system, but the broader principle is consistent: ambient humidity can significantly alter fiber formation. That is why controlled humidity is valuable when working with sensitive materials or when attempting to reproduce a specific morphology across multiple batches.

Temperature and Solution Properties

Temperature also influences electrospinning in several ways. It can affect solution viscosity, solvent vapor pressure, and the overall drying dynamics of the fiber jet. In many systems, a moderate increase in temperature can promote finer fiber formation by lowering viscosity and accelerating solvent evaporation.

At the same time, excessive heat can destabilize certain formulations, especially when working with protein-based or biologically sensitive materials. In those cases, process consistency depends not only on the electrospinning parameters themselves, but also on maintaining a stable and appropriate thermal environment throughout the run.

 

The Link Between Environment and Reproducibility

One of the biggest challenges in electrospinning is reproducibility. A process that works well on one day may behave differently on another if the lab environment changes. Seasonal shifts, air conditioning, ventilation, or simple humidity fluctuations can all influence the final fiber structure.

This is especially relevant when moving from exploratory research to more structured process development. If the goal is to compare formulations, optimize a scaffold, or build a scalable process, then environmental drift can make results harder to interpret. A controlled environment helps reduce this variability and makes it easier to isolate the effect of each process parameter.

The ECU addresses this need by providing active control over the chamber atmosphere. That gives researchers a more stable platform for comparing conditions, refining recipes, and documenting process behavior more consistently.

 

What the Fluidnatek ECU Brings to the Process

Fluidnatek’s Environmental Control Unit is designed to support electrospinning under controlled conditions by regulating temperature and humidity within the chamber. It is available as an integrated option across the Fluidnatek platform range and is intended to help users manage the climate conditions that affect fiber formation.

The ECU combines environmental stability with practical process support. According to Fluidnatek’s product positioning, it enables heating, cooling, drying, and humidifying of the chamber atmosphere, allowing users to explore the viable climate space for each process more effectively. This flexibility is particularly useful when working with polymers or solvents that respond differently to ambient conditions.

The system also supports a clean processing environment through HEPA filtration at the air intake stage. For biomedical and research applications, that added environmental control can be helpful when working toward more consistent and defensible results.

 

Applications Where Environmental Control Makes a Difference

Biomedical Scaffolds and Implantable Devices

In biomedical electrospinning, morphology matters. Fiber diameter, surface texture, and porosity all influence how a scaffold behaves in contact with cells and tissue. For applications such as wound dressings, vascular grafts, hernia meshes, and nerve guides, stable environmental conditions can help improve the consistency of the final material.

Polymer systems used in biomedical applications may be particularly sensitive to ambient changes. For that reason, the ability to control humidity and temperature during electrospinning can support more reliable scaffold development and more consistent batch-to-batch performance.

 

Drug Delivery and Functional Materials

Environmental control is also valuable in drug delivery work, where fiber morphology can affect loading behavior, surface characteristics, and release performance. In these cases, uncontrolled humidity may alter the way the fiber forms and dries, which can introduce unwanted variability.

Using a controlled chamber environment helps reduce one major source of uncertainty during process development. That makes it easier to compare formulations, evaluate design space, and make more confident decisions about process optimization.

 

Protein-Based Biomaterials

Protein-based electrospinning systems are often more sensitive than synthetic polymers. Materials such as collagen or gelatin may respond strongly to both temperature and humidity, which makes a stable processing environment even more important.

For these applications, environmental control can help preserve process consistency and reduce the likelihood of morphological defects. It also supports a more predictable workflow when researchers need to repeat experiments, compare formulations, or document results for publication or future scale-up.

Fluidnatek LE-500 + ECU_front view

Fluidnatek LE-500 and ECU.

Environmental Control and Scale-Up

Environmental control becomes even more important as electrospinning moves from lab-scale development to larger or more formalized production settings. At a larger scale, minor fluctuations in airflow, vapor accumulation, or chamber conditions can have a greater effect on fiber consistency.

A controlled chamber helps reduce one of the common variables that can complicate scale-up. By keeping temperature and humidity within a defined range, researchers and manufacturers can work toward more repeatable results across different systems and production settings.

This is where the ECU fits naturally into Fluidnatek’s broader platform approach. It is designed to support process development, product optimization, and the transition from exploratory research to more controlled production workflows.

 

Why the ECU Fits Fluidnatek’s Platform Strategy

The ECU is not a general-purpose climate accessory. It is part of a system designed specifically for electrospinning, where temperature, humidity, and airflow must be considered together.

That matters because electrospinning is not a static process. It is sensitive to the interaction between the solution, the jet, the collector, and the surrounding atmosphere. A controlled chamber gives users more flexibility to explore those interactions while reducing the noise introduced by uncontrolled ambient conditions.

For researchers, that means better experimental control and easier comparison between runs. For process developers, it means a more stable route toward reproducibility. And for teams working on biomedical or regulated applications, it helps support a cleaner and more consistent process environment.

Conclusion

Environmental control is a fundamental part of electrospinning process development. Temperature and humidity can strongly influence fiber morphology, diameter distribution, and reproducibility, making them essential variables to manage when working on high-value applications.

Fluidnatek’s Environmental Control Unit is designed to provide that stability within the electrospinning chamber. By supporting controlled heating, cooling, drying, humidification, and HEPA-filtered air intake, the ECU helps users create a more consistent processing environment for research and development.

For teams developing biomedical scaffolds, drug delivery systems, or other electrospun materials, that controlled environment can make the difference between a promising result and a repeatable process.

Looking to improve reproducibility in your electrospinning work? Fluidnatek’s Environmental Control Unit provides the controlled chamber conditions you need to support better fiber morphology, more consistent results, and more confident process development.

Contact our technical team to learn how the ECU can support your application.

 

References

Casper, C. L., Stephens, J. S., Tassi, N. G., Chase, D. B., & Rabolt, J. F. (2004). Controlling surface morphology of electrospun polystyrene fibers: Effect of humidity and molecular weight in the electrospinning process. Macromolecules, 37(2), 573–578. https://doi.org/10.1021/ma0351975

Nezarati, R. M., Eifert, M. B., & Cosgriff-Hernandez, E. (2013). Effects of humidity and solution viscosity on electrospun fiber morphology. Tissue Engineering Part C: Methods, 19(10), 810–819. https://doi.org/10.1089/ten.tec.2012.0671

Samad, U. A., Alam, M. A., Al-Zahrani, S. M., & Sherif, E. S. M. (2020). Effect of humidity on formation of electrospun polycaprolactone nanofiber embedded with curcumin using needleless electrospinning. Procedia Manufacturing, 43. https://doi.org/10.1016/j.promfg.2020.02.193

Xue, J., Wu, T., Dai, Y., & Xia, Y. (2019). Electrospinning and electrospun nanofibers: Methods, materials, and applications. Chemical Reviews, 119(8), 5298–5415. https://doi.org/10.1021/acs.chemrev.8b00593

Omer, S., Forgách, L., Zelkó, R., & Sebe, I. (2021). Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes. Pharmaceutics, 13(2), 286. https://doi.org/10.3390/pharmaceutics13020286

Vass, P., et al. (2020). Scale-up of electrospinning technology: Applications in the pharmaceutical industry. WIREs Nanomedicine and Nanobiotechnology, 12(4), e1611. https://doi.org/10.1002/wnan.1611

Fluidnatek. (2024). Electrospinning Environmental Control Unit (ECU). Bioinicia Fluidnatek SLU. https://fluidnatek.com/advanced-electrospinning-equipment/electrospinning-environmental-control/

Fluidnatek, at the Spain–United States Business Summit

Boston biotech hub

Boston as a Global Biotech Innovation Ecosystem

Boston continues to position itself as one of the most concentrated and dynamic biotech hubs worldwide—bringing together leading research institutions, startups, established companies, and investors within a highly collaborative environment. This unique ecosystem makes the city a key reference point for advances in biomedical innovation, biotechnology, and medical device development.

At Fluidnatek, our participation in the Spain–United States Business Summit goes beyond event attendance. It is part of a broader strategy to remain closely aligned with the evolving needs of the biomedical and medical device sectors, particularly in areas where advanced materials and scalable manufacturing technologies are critical.

Strengthening Transatlantic Collaboration in Life Sciences

This initiative, promoted by ICEX in collaboration with Richi Foundation and local partners, brings together Spanish and US companies to foster collaboration in life sciences, biotechnology, and advanced technologies. Such platforms are essential to accelerate innovation and facilitate knowledge exchange across international ecosystems.

Boston_ICEX biotech summit

Fernando Corral -Operations Manager-, and Enrique Navarro -Sales & Marketing Manager, at the Spain-United States Business Summit.

Key Focus Areas in the Boston Life Science Ecosystem

In recent days, we have engaged with companies and innovation platforms across the Boston life sciences landscape—from early-stage ventures to well-established organisations—sharing perspectives on current challenges and opportunities in areas such as:

  • Advanced biomaterials and tissue engineering
  • Drug delivery systems and functional coatings
  • Scalable manufacturing of nanostructured materials

These domains are closely linked to the growing demand for electrospinning technologies and nanofiber-based solutions, particularly where performance, reproducibility, and scalability are key requirements.

Electrospinning and Nanofiber Technologies in Real-World Applications

Experiencing the level of innovation and commitment within the Boston ecosystem is truly inspiring. The energy surrounding these projects highlights the importance of translating research into practical, impactful solutions.

At Fluidnatek, the continuous improvement of our electrospinning platforms is directly shaped by these interactions. By listening to researchers and industry leaders, we ensure that our technology evolves in line with real application needs—from laboratory research to scalable nanofiber production.

Our presence in the US is well established. Over the years, we have supported this ecosystem by providing advanced nanofiber production technologies, enabling developments in biomedical applications, filtration, and beyond. Our commitment remains clear: to ensure that electrospinning moves beyond experimental settings and becomes a reliable, scalable manufacturing solution.

Driving Innovation Through Collaboration

Ultimately, meaningful innovation is driven by collaboration. Conversations with researchers, startups, and industry leaders are essential to identify challenges, refine technologies, and accelerate progress in the field of nanofiber-based biomedical applications.

👉 If you are working on biomedical applications involving nanofibers or electrospinning technologies, we invite you to get in touch with our team. Let’s explore how we can support your developments and collaborate on bringing scalable solutions to market.

Electrospun Tropoelastin Characterization: Fraunhofer IMWS Microscopy

electrospun tropoelastin characterization

Introduction: Characterizing Biomaterials at the Nanoscale

In regenerative medicine and biomedical engineering, the structural characteristics of biomaterials at the micro- and nanoscale play a decisive role in determining their biological performance. Cell adhesion, proliferation, and tissue integration are strongly influenced by surface morphology, mechanical properties, and scaffold architecture. Consequently, advanced biomaterial characterization techniques are essential for validating new materials intended for biomedical applications.

Among the many fabrication technologies used in tissue engineering, electrospinning has emerged as one of the most versatile methods for producing nanofiber scaffolds that resemble the fibrous architecture of the extracellular matrix (ECM). Electrospun biomaterials can provide highly porous, interconnected structures that support cell–material interactions and tissue regeneration (Almine et al., 2010).

To ensure that electrospun biomaterials meet the requirements for biomedical use, detailed microscopy analysis and nanofiber characterization are required. Techniques such as scanning electron microscopy (SEM) allow researchers to investigate fiber morphology, structural organization, and surface features at high resolution.

A collaborative research initiative involving Skinomics GmbH, Martin Luther University Halle-Wittenberg, and the Fraunhofer Institute for Microstructure of Materials and Systems IMWS is currently investigating innovative wound dressing materials based on human tropoelastin. The goal of this project is to develop customized biomaterials that combine biocompatibility, biodegradability, durability, and mechanical properties comparable to those of human skin (Fraunhofer IMWS, 2024). In this context, advanced Fraunhofer IMWS microscopy techniques are being used to characterize the structure and morphology of tropoelastin-based materials. Such characterization is a critical step in evaluating the biomedical potential of electrospun protein-based scaffolds.

Tropoelastin Nanofibers for Biomedical Applications and Tissue Engineering

What Is Tropoelastin and Why Is It Important in Biomedicine?

Tropoelastin is the soluble precursor of elastin, a structural protein that plays a fundamental role in maintaining the elasticity and resilience of many tissues in the human body. Elastin is present in the vasculature, skin, and lungs, where it enables tissues to stretch and return to their original shape (Wise, Mithieux & Weiss, 2009).

During biological processes, tropoelastin molecules assemble and crosslink to form elastin fibers. These fibers contribute to the mechanical stability and elasticity of tissues, making elastin an essential component of the extracellular matrix. Elastin is one of the most long-lived proteins in the human body, with a half-life that can span decades in tissues with low cellular turnover (Mithieux, Wise & Weiss, 2012).

According to the Fraunhofer IMWS project description, elastin is chemically and enzymatically stable, biocompatible, and inspires designs for tropoelastin-based materials with sustained mechanical performance in biological environments, given its long half-life in native tissues. These characteristics have motivated the development of tropoelastin-based biomaterials. By using the precursor protein of elastin, researchers aim to create materials that reproduce the mechanical and biological functions of native tissues (Fraunhofer IMWS, 2024).

As Dr. Christian Schmelzer, Head of the Department of Biological and Macromolecular Materials at Fraunhofer IMWS, stated: “Elastin is chemically and enzymatically extremely stable, biocompatible and does not produce immunological rejections when used as a biomaterial in humans. Therefore, we want to create new and innovative solutions for the treatment of complex wounds based on human tropoelastin” (Fraunhofer IMWS, 2024).

An additional motivation for developing tropoelastin-based materials lies in the limitations of conventional protein biomaterials derived from animal tissues. Animal-derived materials can pose risks of pathogen transmisión or unwanted immune reactions. Moreover, concerns about animal-derived medical products have increased among patients and healthcare providers. The use of human-derived recombinant tropoelastin may reduce such concerns while maintaining favorable mechanical and biological properties (Wise, Mithieux & Weiss, 2009).

Microstructure of a tropoelastin nonwoven

Microstructure of a tropoelastin nonwoven. Image: Fraunhofer IMWS

Electrospinning of Tropoelastin-Based Nanofibers

Electrospinning is widely used to fabricate electrospun biomaterials with nanoscale fibrous structures that mimic the architecture of the extracellular matrix. The technique involves the application of a high electric field to a polymer or protein solution, generating ultrafine fibers that are deposited as nonwoven membranes.

The electrospinning of tropoelastin has been studied as a method for producing porous protein scaffolds. Research has shown that the morphology of electrospun tropoelastin fibers can be modulated by varying spinning parameters such as delivery flow rate and starting protein concentration, and that cross-linked electrospun scaffolds retain the elasticity and cell-interactive properties inherent in the tropoelastin precursor (Wise, Mithieux & Weiss, 2009).

Electrospun scaffolds typically exhibit several characteristics that are advantageous for biomedical applications:

  • High surface-to-volume ratio
  • Porous fibrous architecture
  • Structural similarity to extracellular matrix networks
  • Tunable fiber diameter and scaffold morphology

In the Fraunhofer-associated research project, tropoelastin-based materials are being developed as customized wound dressing materials, specifically targeting the treatment of chronic and complex wounds. These conditions represent a major challenge in healthcare, particularly in aging populations. Chronic wounds such as venous ulcers, leg ulcers, and foot ulcers often require long-term treatment and can significantly affect patients’ quality of life (Fraunhofer IMWS, 2024). These conditions are also associated with considerable healthcare costs. Preclinical tests described in the Fraunhofer IMWS project documentation indicate that the tropoelastin-based material developed within the collaboration is a promising candidate for use as a wound dressing in such contexts. The material combines biocompatibility, biodegradability, durability, and favorable mechanical behavior.

Microscopy Techniques for Electrospun Biomaterial Characterization

SEM and Microscopy Techniques for Nanofiber Characterization Analyzing the structural properties of electrospun biomaterials requires detailed nanofiber characterization techniques capable of resolving features at the micro- and nanoscale. Microscopy methods are essential tools in biomaterials research for this purpose.

Among the techniques commonly used in the field to analyze electrospun scaffolds are:

  • Scanning Electron Microscopy (SEM): provides high-resolution images of fiber networks, enabling evaluation of fiber uniformity, diameter distribution, and structural integrity.

Transmission Electron Microscopy (TEM): allows investigation of internal fiber structure and nanoscale features.

  • Atomic Force Microscopy (AFM): used to assess surface topography and nanomechanical properties of individual fibers.
  • Optical microscopy: applied for preliminary morphological assessment and scaffold-level organization.

Scanning Electron Microscopy is instrumental analysis for evaluating electrospun protein-based scaffolds, as it enables high-resolution visualization of nanofiber topographies. Through SEM-based morphometric analysis, critical parameters—including fiber diameter distribution, uniformity, and overall architecture can be quantified, providing essential insights into the materials performance within biological environments.

Fraunhofer IMWS Research on Elastin-Like Materials

The Fraunhofer Institute for Microstructure of Materials and Systems IMWS specializes in the structural characterization of advanced materials. Within the tropoelastin research project, the institute applies microscopy techniques to analyze the morphology and structural properties of the developed biomaterials (Fraunhofer IMWS, 2024).

By combining electrospinning with detailed microstructural characterization, the research team can evaluate how the processing of tropoelastin-based materials influences their final structural and mechanical properties. These analyses provide insights into key aspects such as:

  • Fiber morphology and structural organization
  • Scaffold architecture and fiber distribution
  • Surface morphology of the nanofibers
  • Potential relationships between microstructure and material performance
Electrospun nonwoven of biotechnologically produced tropoelastin

Electrospun nonwoven of biotechnologically produced tropoelastin. Image: Fraunhofer IMWS.

Material Properties of the Tropoelastin-Based Wound Dressing

The collaborative project aims to create customized wound dressings based on tropoelastin biomaterials. According to the Fraunhofer IMWS project description, the developed material demonstrates a combination of properties that are particularly relevant for wound care applications (Fraunhofer IMWS, 2024):

  • Biocompatibility
  • Biodegradability
  • Mechanical properties comparable to human skin in preclinical assessments
  • Durability suitable for biomedical use

These characteristics are essential for wound dressing materials intended to support tissue regeneration while maintaining mechanical compatibility with the surrounding tissue. An important aspect highlighted in the project documentation is the similarity between the mechanical properties of the tropoelastin-based material and those of human skin—a property that can be attributed to the role of elastin in conferring skin elasticity and resilience (Wise, Mithieux & Weiss, 2009). Microscopy characterization is central to evaluating these structural properties. By analyzing nanofiber morphology and scaffold architecture, researchers can assess whether the material structure supports its intended biomedical function. The detailed characterization results from the Fraunhofer IMWS project are expected to be published in peer-reviewed literature as the project progresses.

Implications for Regenerative Medicine and Biomedical Device Development

The treatment of chronic and complex wounds represents a significant medical challenge, particularly in aging populations. Conditions such as venous ulcers and foot ulcers often require long-term care and can lead to serious complications if not treated effectively (Fraunhofer IMWS, 2024).

Innovative biomaterials are therefore being actively investigated to improve wound healing outcomes. Materials that combine biocompatibility, mechanical compatibility with surrounding tissues, and structural similarity to natural ECM are particularly promising. Tropoelastin-based biomaterials represent one such approach: because tropoelastin is the monomer of elastin, materials derived from it can reproduce structural and mechanical characteristics relevant to skin and other elastic tissues (Almine et al., 2010).

The use of human-derived recombinant protein materials also addresses concerns associated with animal-derived biomaterials, including potential infection risks and immune responses. This is a recognized advantage in the development of next-generation protein biomaterials for clinical use (Wise, Mithieux & Weiss, 2009).

The integration of electrospinning technologies with advanced biomaterial characterization enables researchers to systematically investigate these materials. Through high-resolution microscopy and structural analysis, researchers can evaluate whether electrospun tropoelastin scaffolds exhibit the morphological and mechanical properties required for biomedical applications.

Such interdisciplinary approaches—combining biomaterials science, nanofiber fabrication, and microscopy analysis—are central to the development of next-generation biomaterials for regenerative medicine and wound care.

Conclusion

The development of customized wound dressings based on human tropoelastin represents a significant and scientifically grounded direction in biomaterials research. By leveraging the properties of the soluble elastin precursor, researchers aim to create biomaterials that replicate the elasticity and resilience of natural skin tissue.

The collaborative project involving Skinomics GmbH, Martin Luther University Halle-Wittenberg, and Fraunhofer IMWS highlights the importance of combining biomaterial design with advanced structural characterization. Microscopy analysis

plays a key role in understanding the fiber morphology and scaffold architecture of electrospun tropoelastin materials, ensuring they meet the requirements for biomedical applications.

Continued advancements in the characterization and fabrication of tropoelastin-based materials may transform the treatment for non-healing wounds, offering a biomimetic foundation for innovative tissue engineering applications.

Looking to Develop and Validate Innovative Biomaterials Like Tropoelastin?

Fluidnatek supports advanced electrospinning projects for the production of electrospun biomaterials and nanofiber scaffolds tailored for biomedical research and regenerative medicine applications. Whether your project involves protein-based materials, ECM-mimicking scaffolds, or wound care devices, our platforms are designed to support rigorous research in collaboration with institutions such as Fraunhofer IMWS.

Contact Fluidnatek to discuss how our electrospinning solutions can support your biomaterial development pipeline.

References

Almine, J. F., Bax, D. V., Mithieux, S. M., Nivison-Smith, L., Rnjak, J., Waterhouse, A., Wise, S. G., & Weiss, A. S. (2010). Elastin-based materials. Chemical Society Reviews, 39(9), 3371–3379. https://doi.org/10.1039/b919452p

Fraunhofer Institute for Microstructure of Materials and Systems IMWS. (2024). Innovative wound care – customized wound dressings made from tropoelastin [Project communication]. Fraunhofer IMWS. https://www.imws.fraunhofer.de

Mithieux, S. M., Wise, S. G., & Weiss, A. S. (2012). Tropoelastin – a multifaceted naturally smart material. Advanced Drug Delivery Reviews, 65(4), 421–428. https://doi.org/10.1016/j.addr.2012.06.009

Wise, S. G., & Weiss, A. S. (2009). Tropoelastin. International Journal of Biochemistry & Cell Biology, 41(3), 494–497. https://doi.org/10.1016/j.biocel.2008.03.017

Wise, S. G., Mithieux, S. M., & Weiss, A. S. (2009). Engineered tropoelastin and elastin-based biomaterials. Advances in Protein Chemistry and Structural Biology, 78, 1–24. https://doi.org/10.1016/S1876-1623(08)78001-5

Blit, P. H., Battiston, K. G., Yang, M., Paul Santerre, J., & Woodhouse, K. A. (2012). Electrospun elastin-like polypeptide enriched polyurethanes and their interactions with vascular smooth muscle cells. Acta Biomaterialia, 8(7), 2493–2503. https://doi.org/10.1016/j.actbio.2012.03.032

INTERESTED? CONTACT OUR SPECIALISTS!
INTERESTED? CONTACT OUR SPECIALISTS!